HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement
HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.
HeartBeam Inc. (NASDAQ: BEAT), a medical technology company specializing in cardiac care solutions, announced a commercial agreement with Atelier Health, a concierge medical practice based in Beverly Hills. The partnership expands HeartBeam’s launch footprint into Southern California, completing its initial targeted markets alongside New York metro, Dallas, and South Florida as the company advances the commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology.
This news matters because it signals HeartBeam’s strategic progress in bringing its innovative technology to key healthcare markets. The company’s 3D ECG system is the first-ever cable-free device capable of collecting ECG signals from three non-coplanar directions and synthesizing them into a 12-lead ECG. This platform is designed for portable use, enabling physicians to identify cardiac health trends and acute conditions outside of medical facilities, potentially transforming cardiac health management.
The FDA clearance for arrhythmia assessment was received in December 2024, and the 12-lead ECG synthesis software received clearance in December 2025. These regulatory milestones, combined with over 20 issued patents, underscore HeartBeam’s technological leadership. The agreement with Atelier Health, a high-end concierge practice, suggests a focus on premium healthcare providers who can offer advanced monitoring to their patients.
For investors, the expansion into Southern California and completion of initial market targets indicate that HeartBeam is executing on its commercialization strategy. The company’s technology addresses a critical need for remote cardiac monitoring, which has become increasingly important in the era of value-based care and telemedicine. By partnering with concierge medicine practices, HeartBeam may accelerate adoption among patients who seek personalized, high-touch healthcare.
For more details, the full press release is available at https://ibn.fm/FvduAA. Additional information about HeartBeam and its cleared indications for use can be found at https://www.heartbeam.com/indications.